Botox 100 unit vials

Ended Awarded

Contract number
SPE2DR26FSFP5
Awardee
Awarding agency
Obligated
$1,440

Award facts

Contract value 100% obligated
$1,439.61 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on July 13, 2026, for $1,439.61 of BOTOX 100 Unit Vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical holds a single-award indefinite delivery contract under PPV-G GEN V with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. PPV-G GEN V is structured with a 30-month base period and three 30-month option periods. Place of performance is Park Ridge, Illinois. The order carries a firm fixed price and ultimate completion date of August 3, 2026. No set-aside was applied.

Quick answers

Who was awarded contract SPE2DR26FSFP5?

SPE2DR26FSFP5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 13, 2026.

How much is contract SPE2DR26FSFP5 worth?

The government has obligated $1,440 on SPE2DR26FSFP5.

Is contract SPE2DR26FSFP5 an order under another contract?

Yes. SPE2DR26FSFP5 is a delivery order under SPE2DR25D9313, an indefinite delivery contract.

Was contract SPE2DR26FSFP5 competed?

The extent of competition for SPE2DR26FSFP5 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award